0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tissue Lysis Buffer Market Research Report 2026
Published Date: 2026-04-16
|
Report Code: QYRE-Auto-39Z16712
Home | Market Reports | Science| Biological Sciences
Global Tissue Lysis Buffer Market Research Report 2024
BUY CHAPTERS

Global Tissue Lysis Buffer Market Research Report 2026

Code: QYRE-Auto-39Z16712
Report
2026-04-16
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tissue Lysis Buffer Market

The global Tissue Lysis Buffer market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Tissue Lysis Buffer competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Tissue lysis buffer is a buffer used for lysing tissue cells in molecular biology experiments and extracting the desired biomolecules, such as proteins, DNA or RNA.
The North American market for Tissue Lysis Buffer is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Tissue Lysis Buffer is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Tissue Lysis Buffer include Roche, Thermo Fisher Scientific, Cell Biologics, Promega, Qiagen, New England Biolabs, AimPlex Biosciences, Immagina BioTechnology, Gold Biotechnology, Sigma-Aldrich, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Tissue Lysis Buffer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tissue Lysis Buffer. The Tissue Lysis Buffer market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Tissue Lysis Buffer market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Tissue Lysis Buffer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Tissue Lysis Buffer Market Report

Report Metric Details
Report Name Tissue Lysis Buffer Market
Segment by Type
  • RIPA Buffer
  • PLT Buffer
  • Cell Lysis Buffer
  • Others
by Application
  • Hospitals
  • Laboratory
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Thermo Fisher Scientific, Cell Biologics, Promega, Qiagen, New England Biolabs, AimPlex Biosciences, Immagina BioTechnology, Gold Biotechnology, Sigma-Aldrich, Takara Bio, Cell Signaling Technology, BD Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Tissue Lysis Buffer manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Tissue Lysis Buffer sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Tissue Lysis Buffer Market report?

Ans: The main players in the Tissue Lysis Buffer Market are Roche, Thermo Fisher Scientific, Cell Biologics, Promega, Qiagen, New England Biolabs, AimPlex Biosciences, Immagina BioTechnology, Gold Biotechnology, Sigma-Aldrich, Takara Bio, Cell Signaling Technology, BD Biosciences

What are the Application segmentation covered in the Tissue Lysis Buffer Market report?

Ans: The Applications covered in the Tissue Lysis Buffer Market report are Hospitals, Laboratory, Other

What are the Type segmentation covered in the Tissue Lysis Buffer Market report?

Ans: The Types covered in the Tissue Lysis Buffer Market report are RIPA Buffer, PLT Buffer, Cell Lysis Buffer, Others

1 Tissue Lysis Buffer Market Overview
1.1 Product Definition
1.2 Tissue Lysis Buffer by Type
1.2.1 Global Tissue Lysis Buffer Market Value by Type: 2025 vs 2032
1.2.2 RIPA Buffer
1.2.3 PLT Buffer
1.2.4 Cell Lysis Buffer
1.2.5 Others
1.3 Tissue Lysis Buffer by Application
1.3.1 Global Tissue Lysis Buffer Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Other
1.4 Global Tissue Lysis Buffer Market Size Estimates and Forecasts
1.4.1 Global Tissue Lysis Buffer Revenue 2021–2032
1.4.2 Global Tissue Lysis Buffer Sales 2021–2032
1.4.3 Global Tissue Lysis Buffer Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Tissue Lysis Buffer Market Competition by Manufacturers
2.1 Global Tissue Lysis Buffer Sales Market Share by Manufacturers (2021–2026)
2.2 Global Tissue Lysis Buffer Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Tissue Lysis Buffer Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Tissue Lysis Buffer, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Tissue Lysis Buffer, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Tissue Lysis Buffer, Product Types and Applications
2.7 Global Key Manufacturers of Tissue Lysis Buffer, Date of Entry into the Industry
2.8 Global Tissue Lysis Buffer Market Competitive Situation and Trends
2.8.1 Global Tissue Lysis Buffer Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Tissue Lysis Buffer Players Market Share by Revenue
2.8.3 Global Tissue Lysis Buffer Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tissue Lysis Buffer Market Scenario by Region
3.1 Global Tissue Lysis Buffer Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Tissue Lysis Buffer Sales by Region: 2021–2032
3.2.1 Global Tissue Lysis Buffer Sales by Region: 2021–2026
3.2.2 Global Tissue Lysis Buffer Sales by Region: 2027–2032
3.3 Global Tissue Lysis Buffer Revenue by Region: 2021–2032
3.3.1 Global Tissue Lysis Buffer Revenue by Region: 2021–2026
3.3.2 Global Tissue Lysis Buffer Revenue by Region: 2027–2032
3.4 North America Tissue Lysis Buffer Market Facts & Figures by Country
3.4.1 North America Tissue Lysis Buffer Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Tissue Lysis Buffer Sales by Country (2021–2032)
3.4.3 North America Tissue Lysis Buffer Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tissue Lysis Buffer Market Facts & Figures by Country
3.5.1 Europe Tissue Lysis Buffer Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Tissue Lysis Buffer Sales by Country (2021–2032)
3.5.3 Europe Tissue Lysis Buffer Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tissue Lysis Buffer Market Facts & Figures by Region
3.6.1 Asia Pacific Tissue Lysis Buffer Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Tissue Lysis Buffer Sales by Region (2021–2032)
3.6.3 Asia Pacific Tissue Lysis Buffer Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tissue Lysis Buffer Market Facts & Figures by Country
3.7.1 Latin America Tissue Lysis Buffer Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Tissue Lysis Buffer Sales by Country (2021–2032)
3.7.3 Latin America Tissue Lysis Buffer Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tissue Lysis Buffer Market Facts & Figures by Country
3.8.1 Middle East and Africa Tissue Lysis Buffer Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Tissue Lysis Buffer Sales by Country (2021–2032)
3.8.3 Middle East and Africa Tissue Lysis Buffer Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tissue Lysis Buffer Sales by Type (2021–2032)
4.1.1 Global Tissue Lysis Buffer Sales by Type (2021–2026)
4.1.2 Global Tissue Lysis Buffer Sales by Type (2027–2032)
4.1.3 Global Tissue Lysis Buffer Sales Market Share by Type (2021–2032)
4.2 Global Tissue Lysis Buffer Revenue by Type (2021–2032)
4.2.1 Global Tissue Lysis Buffer Revenue by Type (2021–2026)
4.2.2 Global Tissue Lysis Buffer Revenue by Type (2027–2032)
4.2.3 Global Tissue Lysis Buffer Revenue Market Share by Type (2021–2032)
4.3 Global Tissue Lysis Buffer Price by Type (2021–2032)
5 Segment by Application
5.1 Global Tissue Lysis Buffer Sales by Application (2021–2032)
5.1.1 Global Tissue Lysis Buffer Sales by Application (2021–2026)
5.1.2 Global Tissue Lysis Buffer Sales by Application (2027–2032)
5.1.3 Global Tissue Lysis Buffer Sales Market Share by Application (2021–2032)
5.2 Global Tissue Lysis Buffer Revenue by Application (2021–2032)
5.2.1 Global Tissue Lysis Buffer Revenue by Application (2021–2026)
5.2.2 Global Tissue Lysis Buffer Revenue by Application (2027–2032)
5.2.3 Global Tissue Lysis Buffer Revenue Market Share by Application (2021–2032)
5.3 Global Tissue Lysis Buffer Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Tissue Lysis Buffer Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Thermo Fisher Scientific Tissue Lysis Buffer Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Cell Biologics
6.3.1 Cell Biologics Company Information
6.3.2 Cell Biologics Description and Business Overview
6.3.3 Cell Biologics Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Cell Biologics Tissue Lysis Buffer Product Portfolio
6.3.5 Cell Biologics Recent Developments/Updates
6.4 Promega
6.4.1 Promega Company Information
6.4.2 Promega Description and Business Overview
6.4.3 Promega Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Promega Tissue Lysis Buffer Product Portfolio
6.4.5 Promega Recent Developments/Updates
6.5 Qiagen
6.5.1 Qiagen Company Information
6.5.2 Qiagen Description and Business Overview
6.5.3 Qiagen Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Qiagen Tissue Lysis Buffer Product Portfolio
6.5.5 Qiagen Recent Developments/Updates
6.6 New England Biolabs
6.6.1 New England Biolabs Company Information
6.6.2 New England Biolabs Description and Business Overview
6.6.3 New England Biolabs Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 New England Biolabs Tissue Lysis Buffer Product Portfolio
6.6.5 New England Biolabs Recent Developments/Updates
6.7 AimPlex Biosciences
6.7.1 AimPlex Biosciences Company Information
6.7.2 AimPlex Biosciences Description and Business Overview
6.7.3 AimPlex Biosciences Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 AimPlex Biosciences Tissue Lysis Buffer Product Portfolio
6.7.5 AimPlex Biosciences Recent Developments/Updates
6.8 Immagina BioTechnology
6.8.1 Immagina BioTechnology Company Information
6.8.2 Immagina BioTechnology Description and Business Overview
6.8.3 Immagina BioTechnology Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Immagina BioTechnology Tissue Lysis Buffer Product Portfolio
6.8.5 Immagina BioTechnology Recent Developments/Updates
6.9 Gold Biotechnology
6.9.1 Gold Biotechnology Company Information
6.9.2 Gold Biotechnology Description and Business Overview
6.9.3 Gold Biotechnology Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Gold Biotechnology Tissue Lysis Buffer Product Portfolio
6.9.5 Gold Biotechnology Recent Developments/Updates
6.10 Sigma-Aldrich
6.10.1 Sigma-Aldrich Company Information
6.10.2 Sigma-Aldrich Description and Business Overview
6.10.3 Sigma-Aldrich Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Sigma-Aldrich Tissue Lysis Buffer Product Portfolio
6.10.5 Sigma-Aldrich Recent Developments/Updates
6.11 Takara Bio
6.11.1 Takara Bio Company Information
6.11.2 Takara Bio Description and Business Overview
6.11.3 Takara Bio Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Takara Bio Tissue Lysis Buffer Product Portfolio
6.11.5 Takara Bio Recent Developments/Updates
6.12 Cell Signaling Technology
6.12.1 Cell Signaling Technology Company Information
6.12.2 Cell Signaling Technology Description and Business Overview
6.12.3 Cell Signaling Technology Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Cell Signaling Technology Tissue Lysis Buffer Product Portfolio
6.12.5 Cell Signaling Technology Recent Developments/Updates
6.13 BD Biosciences
6.13.1 BD Biosciences Company Information
6.13.2 BD Biosciences Description and Business Overview
6.13.3 BD Biosciences Tissue Lysis Buffer Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 BD Biosciences Tissue Lysis Buffer Product Portfolio
6.13.5 BD Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tissue Lysis Buffer Industry Chain Analysis
7.2 Tissue Lysis Buffer Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tissue Lysis Buffer Production Mode & Process Analysis
7.4 Tissue Lysis Buffer Sales and Marketing
7.4.1 Tissue Lysis Buffer Sales Channels
7.4.2 Tissue Lysis Buffer Distributors
7.5 Tissue Lysis Buffer Customer Analysis
8 Tissue Lysis Buffer Market Dynamics
8.1 Tissue Lysis Buffer Industry Trends
8.2 Tissue Lysis Buffer Market Drivers
8.3 Tissue Lysis Buffer Market Challenges
8.4 Tissue Lysis Buffer Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Tissue Lysis Buffer Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Tissue Lysis Buffer Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Tissue Lysis Buffer Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Tissue Lysis Buffer Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Tissue Lysis Buffer Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Tissue Lysis Buffer Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Tissue Lysis Buffer Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Tissue Lysis Buffer Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Tissue Lysis Buffer, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Tissue Lysis Buffer, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Tissue Lysis Buffer, Product Types and Applications
 Table 12. Global Key Manufacturers of Tissue Lysis Buffer, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tissue Lysis Buffer Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tissue Lysis Buffer Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tissue Lysis Buffer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Tissue Lysis Buffer Sales by Region (Units), 2021–2026
 Table 18. Global Tissue Lysis Buffer Sales Market Share by Region (2021–2026)
 Table 19. Global Tissue Lysis Buffer Sales by Region (Units), 2027–2032
 Table 20. Global Tissue Lysis Buffer Sales Market Share by Region (2027–2032)
 Table 21. Global Tissue Lysis Buffer Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Tissue Lysis Buffer Revenue Market Share by Region (2021–2026)
 Table 23. Global Tissue Lysis Buffer Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Tissue Lysis Buffer Revenue Market Share by Region (2027–2032)
 Table 25. North America Tissue Lysis Buffer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Tissue Lysis Buffer Sales by Country (Units), 2021–2026
 Table 27. North America Tissue Lysis Buffer Sales by Country (Units), 2027–2032
 Table 28. North America Tissue Lysis Buffer Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Tissue Lysis Buffer Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Tissue Lysis Buffer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Tissue Lysis Buffer Sales by Country (Units), 2021–2026
 Table 32. Europe Tissue Lysis Buffer Sales by Country (Units), 2027–2032
 Table 33. Europe Tissue Lysis Buffer Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Tissue Lysis Buffer Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Tissue Lysis Buffer Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Tissue Lysis Buffer Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Tissue Lysis Buffer Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Tissue Lysis Buffer Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Tissue Lysis Buffer Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Tissue Lysis Buffer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Tissue Lysis Buffer Sales by Country (Units), 2021–2026
 Table 42. Latin America Tissue Lysis Buffer Sales by Country (Units), 2027–2032
 Table 43. Latin America Tissue Lysis Buffer Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Tissue Lysis Buffer Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Tissue Lysis Buffer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Tissue Lysis Buffer Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Tissue Lysis Buffer Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Tissue Lysis Buffer Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Tissue Lysis Buffer Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Tissue Lysis Buffer Sales (Units) by Type (2021–2026)
 Table 51. Global Tissue Lysis Buffer Sales (Units) by Type (2027–2032)
 Table 52. Global Tissue Lysis Buffer Sales Market Share by Type (2021–2026)
 Table 53. Global Tissue Lysis Buffer Sales Market Share by Type (2027–2032)
 Table 54. Global Tissue Lysis Buffer Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Tissue Lysis Buffer Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Tissue Lysis Buffer Revenue Market Share by Type (2021–2026)
 Table 57. Global Tissue Lysis Buffer Revenue Market Share by Type (2027–2032)
 Table 58. Global Tissue Lysis Buffer Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Tissue Lysis Buffer Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Tissue Lysis Buffer Sales (Units) by Application (2021–2026)
 Table 61. Global Tissue Lysis Buffer Sales (Units) by Application (2027–2032)
 Table 62. Global Tissue Lysis Buffer Sales Market Share by Application (2021–2026)
 Table 63. Global Tissue Lysis Buffer Sales Market Share by Application (2027–2032)
 Table 64. Global Tissue Lysis Buffer Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Tissue Lysis Buffer Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Tissue Lysis Buffer Revenue Market Share by Application (2021–2026)
 Table 67. Global Tissue Lysis Buffer Revenue Market Share by Application (2027–2032)
 Table 68. Global Tissue Lysis Buffer Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Tissue Lysis Buffer Price (US$/Unit) by Application (2027–2032)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Roche Tissue Lysis Buffer Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Thermo Fisher Scientific Company Information
 Table 76. Thermo Fisher Scientific Description and Business Overview
 Table 77. Thermo Fisher Scientific Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Thermo Fisher Scientific Tissue Lysis Buffer Product
 Table 79. Thermo Fisher Scientific Recent Developments/Updates
 Table 80. Cell Biologics Company Information
 Table 81. Cell Biologics Description and Business Overview
 Table 82. Cell Biologics Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Cell Biologics Tissue Lysis Buffer Product
 Table 84. Cell Biologics Recent Developments/Updates
 Table 85. Promega Company Information
 Table 86. Promega Description and Business Overview
 Table 87. Promega Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Promega Tissue Lysis Buffer Product
 Table 89. Promega Recent Developments/Updates
 Table 90. Qiagen Company Information
 Table 91. Qiagen Description and Business Overview
 Table 92. Qiagen Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Qiagen Tissue Lysis Buffer Product
 Table 94. Qiagen Recent Developments/Updates
 Table 95. New England Biolabs Company Information
 Table 96. New England Biolabs Description and Business Overview
 Table 97. New England Biolabs Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. New England Biolabs Tissue Lysis Buffer Product
 Table 99. New England Biolabs Recent Developments/Updates
 Table 100. AimPlex Biosciences Company Information
 Table 101. AimPlex Biosciences Description and Business Overview
 Table 102. AimPlex Biosciences Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. AimPlex Biosciences Tissue Lysis Buffer Product
 Table 104. AimPlex Biosciences Recent Developments/Updates
 Table 105. Immagina BioTechnology Company Information
 Table 106. Immagina BioTechnology Description and Business Overview
 Table 107. Immagina BioTechnology Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Immagina BioTechnology Tissue Lysis Buffer Product
 Table 109. Immagina BioTechnology Recent Developments/Updates
 Table 110. Gold Biotechnology Company Information
 Table 111. Gold Biotechnology Description and Business Overview
 Table 112. Gold Biotechnology Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Gold Biotechnology Tissue Lysis Buffer Product
 Table 114. Gold Biotechnology Recent Developments/Updates
 Table 115. Sigma-Aldrich Company Information
 Table 116. Sigma-Aldrich Description and Business Overview
 Table 117. Sigma-Aldrich Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Sigma-Aldrich Tissue Lysis Buffer Product
 Table 119. Sigma-Aldrich Recent Developments/Updates
 Table 120. Takara Bio Company Information
 Table 121. Takara Bio Description and Business Overview
 Table 122. Takara Bio Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Takara Bio Tissue Lysis Buffer Product
 Table 124. Takara Bio Recent Developments/Updates
 Table 125. Cell Signaling Technology Company Information
 Table 126. Cell Signaling Technology Description and Business Overview
 Table 127. Cell Signaling Technology Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Cell Signaling Technology Tissue Lysis Buffer Product
 Table 129. Cell Signaling Technology Recent Developments/Updates
 Table 130. BD Biosciences Company Information
 Table 131. BD Biosciences Description and Business Overview
 Table 132. BD Biosciences Tissue Lysis Buffer Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. BD Biosciences Tissue Lysis Buffer Product
 Table 134. BD Biosciences Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Tissue Lysis Buffer Distributors List
 Table 138. Tissue Lysis Buffer Customers List
 Table 139. Tissue Lysis Buffer Market Trends
 Table 140. Tissue Lysis Buffer Market Drivers
 Table 141. Tissue Lysis Buffer Market Challenges
 Table 142. Tissue Lysis Buffer Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tissue Lysis Buffer
 Figure 2. Global Tissue Lysis Buffer Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Tissue Lysis Buffer Market Share by Type: 2025 & 2032
 Figure 4. RIPA Buffer Product Picture
 Figure 5. PLT Buffer Product Picture
 Figure 6. Cell Lysis Buffer Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Tissue Lysis Buffer Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Tissue Lysis Buffer Market Share by Application: 2025 & 2032
 Figure 10. Hospitals
 Figure 11. Laboratory
 Figure 12. Other
 Figure 13. Global Tissue Lysis Buffer Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Tissue Lysis Buffer Market Size (US$ Million), 2021–2032
 Figure 15. Global Tissue Lysis Buffer Sales (Units), 2021–2032
 Figure 16. Global Tissue Lysis Buffer Average Price (US$/Unit), 2021–2032
 Figure 17. Tissue Lysis Buffer Report Years Considered
 Figure 18. Tissue Lysis Buffer Sales Share by Manufacturers in 2025
 Figure 19. Global Tissue Lysis Buffer Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Tissue Lysis Buffer Players: Market Share by Revenue in Tissue Lysis Buffer in 2025
 Figure 21. Tissue Lysis Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Tissue Lysis Buffer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Tissue Lysis Buffer Sales Market Share by Country (2021–2032)
 Figure 24. North America Tissue Lysis Buffer Revenue Market Share by Country (2021–2032)
 Figure 25. United States Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Tissue Lysis Buffer Sales Market Share by Country (2021–2032)
 Figure 28. Europe Tissue Lysis Buffer Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Tissue Lysis Buffer Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Tissue Lysis Buffer Revenue Market Share by Region (2021–2032)
 Figure 36. China Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Tissue Lysis Buffer Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Tissue Lysis Buffer Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Tissue Lysis Buffer Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Tissue Lysis Buffer Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Tissue Lysis Buffer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Tissue Lysis Buffer by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Tissue Lysis Buffer by Type (2021–2032)
 Figure 56. Global Tissue Lysis Buffer Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Tissue Lysis Buffer by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Tissue Lysis Buffer by Application (2021–2032)
 Figure 59. Global Tissue Lysis Buffer Price (US$/Unit) by Application (2021–2032)
 Figure 60. Tissue Lysis Buffer Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD